GHSI
2024-06-30 | ||||
|---|---|---|---|---|
| Ocular products | 72,918 | |||
| Cost of goods and services sold | 36,572 | |||
| Gross profit | 36,346 | |||
| Sales and marketing | 8,088 | |||
| General and administrative | 1,395,721 | |||
| Gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property | -13,863 | |||
| Operating expenses | 1,417,672 | |||
| Operating income (loss) | -1,381,326 | |||
| Interest income, net | 117,245 | |||
| Change in fair value of warrant derivative liability | 549,320 | |||
| Cost related to settlement of placement agent warrants | 319,625 | |||
| Nonoperating income (expense) | -751,700 | |||
| Net loss from continuing operations | -2,133,026 | |||
| Income from discontinued operations | 200,923 | |||
| Gain on sale, per statement of operations | 12,742,385 | |||
| Transaction costs related to sale of discontinued operations | 485,952 | |||
| Income (loss) from discontinued operations, net of tax, including portion attributable to noncontrolling interest | 12,457,356 | |||
| Net income (loss) | 10,324,330 | |||
| Basic eps | 8.04 | |||
| Diluted eps | 7.96 | |||
| Basic average shares | 1,284,156 | |||
| Diluted average shares | 1,297,638 | |||